PASADENA, Calif. (NASA PR) — After receiving more than 100 applications, NASA’s Jet Propulsion Laboratory (JPL) in Southern California has selected eight U.S. manufacturers to make a new ventilator tailored for coronavirus (COVID-19) patients.
PASADENA, Calif. (NASA PR) — On April 30, the Food and Drug Administration approved VITAL for a ventilator Emergency Use Authorization. Developed in just 37 days by NASA’s Jet Propulsion Laboratory in response to the coronavirus pandemic, VITAL (short for Ventilator Intervention Technology Accessible Locally) wouldn’t replace current hospital ventilators, which can treat a broader range of medical issues.
PASADENA, Calif. (NASA PR) — A new high-pressure ventilator developed by NASA engineers and tailored to treat coronavirus (COVID-19) patients today was approved by the Food and Drug Administration (FDA) for use under the FDA’s March 24 ventilator Emergency Use Authorization.
Called VITAL (Ventilator Intervention Technology Accessible Locally), the device was developed by engineers at NASA’s Jet Propulsion Laboratory (JPL) in Southern California to free up the nation’s limited supply of traditional ventilators so they may be used on patients with the most severe COVID-19 symptoms.
NASA Innovative Advanced Concepts (NIAC) Phase I Award Amount: $125,000
Lynn Rothschild NASA Ames Research Center
Disease is an inherent part of being alive, and thus disease prevention, diagnosis and treatment will be critical to human deep space missions. Pharmaceuticals are used to diagnose, treat, cure or prevent disease, but suffer from lack of stability on Earth and even more so in the space environment.
WASHINGTON (NASA PR) — NASA has joined the fight against coronavirus (COVID-19) with efforts underway across the country to augment the national response, a few of which were highlighted in a media briefing today.
LONG BEACH, Calif., April 22, 2020 (Virgin Orbit PR) —Virgin Orbit, Sir Richard Branson’s responsive satellite launch company, announced today that regulators at the U.S. Food and Drug Administration (FDA) have granted an Emergency Use Authorization for the immediate delivery and use of a new “bridge” ventilator designed and built by the aerospace firm. With that authorization now in place, Virgin Orbit expects to begin delivering ventilators to hospitals within the next few days.
LONG BEACH, Calif., March 30, 2020 (Virgin Orbit PR — Virgin Orbit has developed a new mass-producible bridge ventilator to help in the fight against the coronavirus (COVID-19) pandemic. The Virgin Orbit team has been consulting with the Bridge Ventilator Consortium (BVC), led by the University of California Irvine (UCI) and the University of Texas at Austin (UT Austin), a group formed to spawn and nurture efforts to build producible, simple ventilators to aid in the current COVID-19 crisis.
Pending clearance by the Food and Drug Administration (FDA), Virgin Orbit aims to commence production at its Long Beach manufacturing facility in early April, sprinting to deliver units into the hands of first responders and healthcare professionals as soon as possible.